The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the Connect ^Ⓡ MM Registry.

Autor: Abonour R; Department of Medicine, Division of Hematology/Oncology, Indiana University, Indianapolis, IN. Electronic address: rabonour@iu.edu., Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Rifkin R; Rocky Mountain Cancer Centers US Oncology, Denver, CO., Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, FL., Omel J; Myeloma Research Advocate/Advisor, Grand Island, NE., Hardin JW; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC., Narang M; Maryland Oncology Hematology, US Oncology Research, Columbia, MD., Toomey K; Steeplechase Cancer Center, Somerville, NJ., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC., Wagner LI; Department of Health Policy and Management, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Terebelo H; Providence Cancer Institute, Southfield, MI., Mouro J; Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, Switzerland., Dhanasiri S; Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, Switzerland., Liu L; Bristol Myers Squibb, Princeton, NJ., Yu E; Bristol Myers Squibb, Princeton, NJ., Jagannath S; Department of Medicine, Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e336-e343. Date of Electronic Publication: 2024 Jun 03.

Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.

Autor: Cafardi J; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio., Miller C; Ascension St Agnes Cancer Institute, Baltimore, Maryland., Terebelo H; Ascension St John Newland Medical Associates, Southfield, Michigan., Tewell C; Ascension Medical Group St Vincent Carmel Infectious Disease, Carmel, Indiana., Benzaquen S; Albert Einstein Medical Center, Philadelphia, Pennsylvania., Park D; Providence St Jude Medical Center, Providence Medical Foundation, Fullerton, California., Egan P; Lifespan Cancer Institute, Rhode Island Hospital, Providence., Lebovic D; Ascension St John Hospital, Detroit, Michigan., Pettit K; Bone Marrow Transplant & Leukemia Clinic, C. S. Mott Children's Hospital, Ann Arbor, Michigan., Whitman E; Atlantic Health System, Morristown, New Jersey., Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Buckley S; CTI BioPharma, Seattle, Washington., Roman-Torres K; CTI BioPharma, Seattle, Washington., Smith J; CTI BioPharma, Seattle, Washington., Craig A; CTI BioPharma, Seattle, Washington., Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Dec 01; Vol. 5 (12), pp. e2242918. Date of Electronic Publication: 2022 Dec 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Autor: Du Z; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Weinhold N; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR., Song GC; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Rand KA; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Van Den Berg DJ; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Hwang AE; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Sheng X; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Hom V; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL., Nooka AK; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Singhal S; Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL., Pawlish K; Cancer Epidemiology Services, Epidemiology, Environmental and Occupational Health Division, New Jersey Department of Health, Trenton, NJ., Peters ES; Department of Epidemiology, Louisiana State University School of Public Health, New Orleans, LA., Bock C; Karmanos Cancer Center, Wayne State University, Detroit, MI., Mohrbacher A; Division of Hematology, Department of Medicine, University of Southern California, Los Angeles, CA., Stram A; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Berndt SI; Division of Cancer Genetics and Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Blot WJ; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Casey G; Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA., Stevens VL; American Cancer Society, Atlanta, GA., Kittles R; City of Hope National Medical Center, Duarte, CA., Goodman PJ; The Southwest Oncology Group Statistical Center, Seattle, WA., Diver WR; American Cancer Society, Atlanta, GA., Hennis A; Department of Preventive Medicine, Stony Brook University, Stony Brook, NY., Nemesure B; Department of Preventive Medicine, Stony Brook University, Stony Brook, NY., Klein EA; Cleveland Clinic Foundation, Cleveland, OH., Rybicki BA; Henry Ford Hospital, Detroit, MI., Stanford JL; Fred Hutchinson Cancer Center, Seattle, WA., Witte JS; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA., Signorello L; Division of Cancer Genetics and Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., John EM; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Bernstein L; City of Hope National Medical Center, Duarte, CA., Stroup AM; Cancer Epidemiology Services, Epidemiology, Environmental and Occupational Health Division, New Jersey Department of Health, Trenton, NJ.; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Rutgers University, New Brunswick, NJ., Stephens OW; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR., Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR., Van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR., Olshan A; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC., Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Hu JJ; Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Ziegler R; Division of Cancer Genetics and Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Nyante SJ; Department of Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Ingles SA; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Press MF; Department of Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Carpten JD; Center for Translational Genomics, Department of Translational Genomics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Chanock SJ; Division of Cancer Genetics and Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Mehta J; Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL., Colditz GA; Division of Oncology, Washington University School of Medicine, Saint Louis, MO., Wolf J; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA., Martin TG; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA., Tomasson M; Division of Hematology, Oncology and Bone Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA., Fiala MA; Division of Oncology, Washington University School of Medicine, Saint Louis, MO., Terebelo H; Providence Hospital, Southfield, MI., Janakiraman N; Division of Hematology-Oncology, Henry Ford Hospital, Detroit, MI., Kolonel L; University of Hawaii Cancer Center, Honolulu, HI., Anderson KC; J. Lipper Cancer Center for Multiple Myeloma, Dana-Farber Cancer Institute, Harvard University, Boston, MA., Le Marchand L; University of Hawaii Cancer Center, Honolulu, HI., Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT., Chiu BC; Department of Public Health Sciences, University of Chicago, Chicago, IL., Ziv E; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA., Stram D; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Vij R; Division of Oncology, Washington University School of Medicine, Saint Louis, MO., Bernal-Mizrachi L; Grady Memorial Hospital, Emory University, Atlanta, GA., Morgan GJ; Myeloma Center, Perlmutter Cancer Center, New York University, New York, NY., Zonder JA; Karmanos Cancer Center, Wayne State University, Detroit, MI., Huff CA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; and., Lonial S; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Orlowski RZ; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Conti DV; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Haiman CA; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA., Cozen W; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA.; Department of Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA.

Publikováno v: Blood advances [Blood Adv] 2020 Jan 14; Vol. 4 (1), pp. 181-190.

Clinical Outcomes in Patients (Pts) With Newly Diagnosed Multiple Myeloma (NDMM) and t(4;14) in the Connect MM® Registry

Autor: Shah, J.J., Narang, M., Abonour, R., Mehta, J., Terebelo, H., Gasparetto, C.J., Toomey, K., Hardin, J.W., Srinivasan, S., Larkins, G., Nagarwala, Y., Rifkin, R.M.

Publikováno v: In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e137-e138